Hypertension and Diabetes
Overview
Nephrology
Authors
Affiliations
Hypertension is often associated clinically with diabetes either as part of the insulin resistance syndrome or as a manifestation of renal disease. Elevated systemic blood pressure accelerates the progression of both microvascular and macrovascular complications in diabetes. Agents that interrupt the renin-angiotensin system confer renoprotection via a range of hemodynamic and nonhemodynamic mechanisms. Recent clinical trials confirm that these agents confer renoprotection in type 1 and type 2 diabetic patients with early or advanced renal disease. Hypertension also appears to accelerate vascular and cardiac abnormalities in diabetes, including increased atherosclerosis, arterial stiffness, left ventricular hypertrophy and diastolic dysfunction. A number of recently published and ongoing trials are exploring the role of aggressive antihypertensive treatment with a range of antihypertensive drugs in diabetic subjects at risk of or with macrovascular disease.
Geo-behavioural predictors of diagnosed hypertension in Igbo Ora Area, Oyo State, Nigeria.
Taiwo O, Akinyemi J, Adebayo A, Popoola O, Akinyemi R, Akpa O BMC Public Health. 2025; 25(1):461.
PMID: 39910619 PMC: 11796143. DOI: 10.1186/s12889-025-21653-3.
Hung W, Sutopo C, Mahatmanto T, Wu M, Hsu J Biomedicines. 2024; 12(11).
PMID: 39595018 PMC: 11591893. DOI: 10.3390/biomedicines12112452.
Shahab M, Zheng G, Alshabrmi F, Bourhia M, Wondmie G, Salamatullah A Front Mol Biosci. 2023; 10:1271569.
PMID: 38053577 PMC: 10694256. DOI: 10.3389/fmolb.2023.1271569.
Jannapureddy S, Sharma M, Yepuri G, Schmidt A, Ramasamy R Front Endocrinol (Lausanne). 2021; 12:636267.
PMID: 33776930 PMC: 7992003. DOI: 10.3389/fendo.2021.636267.
Princewel F, Nambile Cumber S, Kimbi J, Nkfusai C, Keka E, Viyoff V Pan Afr Med J. 2020; 34:147.
PMID: 32117515 PMC: 7025826. DOI: 10.11604/pamj.2019.34.147.17518.